Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03MUM
|
||||
Former ID |
DIB009194
|
||||
Drug Name |
EDONENTAN HYDRATE
|
||||
Synonyms |
Edonentan hydrate < USAN; Prop INNM >; BMS-207940 (anhydrous); BMS-207940-02; N-[2'-(4,5-Dimethylisoxazol-3-ylsulfamoyl)-4-(2-oxazolyl)biphenyl-2-ylmethyl]-N,3,3-trimethylbutyramide hydrate
|
||||
Indication | Pulmonary arterial hypertension [ICD9: 416; ICD10:I27.0, I27.2] | Discontinued in Phase 2 | [547387] | ||
Structure |
Download2D MOL |
||||
Canonical SMILES |
CN(Cc1cc(ccc1c2ccccc2S(=O)(=O)Nc3noc(C)c3C)c4occn4)C(=O<br />)CC(C)(C)C
|
||||
InChI |
1S/C28H32N4O5S/c1-18-19(2)37-30-26(18)31-38(34,35)24-10-8-7-9-23(24)22-12-11-20(27-29-13-14-36-27)15-21(22)17-32(6)25(33)16-28(3,4)5/h7-15H,16-17H2,1-6H3,(H,30,31)
|
||||
InChIKey |
ORJRYNKVKJAJPY-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Endothelin-1 receptor | Target Info | Antagonist | [550931], [551871] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Endothelin signaling pathway | ||||
Pathway Interaction Database | Endothelins | ||||
EGFR-dependent Endothelin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.